Actavis UK / Auden Mckenzie merger inquiry

The CMA investigated the anticipated acquisition by Actavis UK Limited of Auden Mckenzie Holdings Ltd.

• From: Competition and Markets Authority
• Published: 30 March 2015
• Last updated: 30 June 2015 — See all updates

• Case type: Mergers
• Case state: Closed
• Market sector: Pharmaceuticals
• Outcome: Mergers - phase 1 clearance
• Opened: 30 March 2015
• Closed: 30 June 2015

Statutory timetable

Phase 1 date	Action
30 June 2015	Decision published
21 May 2015	Decision announced
30 March to 15 April 2015	Invitation to comment
30 March 2015	Launch of merger inquiry

Phase 1

CMA clearance decision

21 May 2015: The CMA has cleared the anticipated acquisition by Actavis UK Limited of Auden Mckenzie Holdings Ltd. The full text of the decision will be available shortly.

• Full text decision (30.6.15)

Invitation to comment: Now closed

30 March 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

Launch of merger inquiry

30 March 2015: The CMA launched its merger inquiry following receipt of a satisfactory notification.

• Commencement of initial period notice (30.3.15)

Contact

Please send written representations about any competition issues to:

Thomas Wood
Competition and Markets Authority
Victoria House
Southampton Row
London
WC1B 4AD

[email protected]

Published 30 March 2015
Last updated 30 June 2015 + show all updates

1. 30 June 2015

   Full text of the decision published.

2. 30 March 2015

   First published.